Category Archives: Longevity Medicine

TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- ReGen Scientific, a leader in personalized, preventative, and regenerative health announced today it will become the first comprehensive health clinic in Canada to bringSynaptive Medicals Evry, a superconducting 0.5T head magnetic resonance imaging (MRI) system intended to provide MRI directly at the point-of-care, to their downtown Toronto location.

Maintaining a healthy brain during ones life is the uppermost goal in pursuing health and longevity, said Dr. Robert Francis, chairman and co-founder of ReGen Scientific. The information and images provided by Evry will inform and support our team of medical professionals in developing personalized proactive strategies to maintain and or restore brain health and cognitive performance to improve quality of life.

At the heart of ReGen Scientifics mission is to change the way health is measured and care is delivered with a hyper-personalized approach to health and wellness. With ReGen Scientifics adoption of Evry, for the first time ever, high performance MRI technology will become accessible directly at a patients point of care within a health clinic, giving doctors vital and potentially life-saving information when and where they need it most, said Cameron Piron, president and co-founder of Synaptive Medical. Our team spent years developing Evry and we are excited to partner with an already established Canadian leader in preventative health, ReGen Scientific, to bring this technology to Canadians seeking to understand the health of their brain well before issues arise.

Evry, which received Health Canada approval in February 2020 and FDA clearance in April of 2020, is currently being used in connection with multiple research studies being done at the QEII Health Sciences Centre in Halifax, Nova Scotia including neuroimaging of stroke and tumor patients, with research funding also having been received to assess and track the impact that COVID-19 may have on the brain.

There are increasing scientific studies revealing that recovery from COVID-19 is a long-haul, meaning survivors continue to suffer debilitating illness and symptoms months after having it. This has created a COVID-19 long-haulers global patient movement seeking help with understanding what has happened within their bodies.

Jean-Marc MacKenzie, CEO and co-founder of ReGen Scientific indicated, ReGen Scientific is looking forward to supporting critical medical research on COVID-19 long-haulers, but more importantly, working to identify treatments that will assist individuals overcome with any lingering effects of COVID-19.

About ReGen Scientific Inc.

ReGen Scientific, is a Toronto based leader in personalized, preventative, and regenerative health. It is accelerating the loop between discovery medical science and evolutions in clinical and functional medicine. ReGen delivers hyper-personalized care based on its Science of You, which enables individuals to take control of their health with an objective of not only extending years lived but the ability to live those years with vitality and health. ReGen Scientific will launch its much-anticipated Toronto based Health Institute, in April 2021. This medical campus will offer the latest in health informatics, genetic testing, predictive screening, regenerative treatments, therapeutics, anti-aging research and functional medicine.

About Synaptive Medical

Synaptive Medical Inc., a Toronto-based, global medical device and technology company solves surgical, imaging, and data challenges to improve the quality of human lives. Synaptives integrated suite of products bridging MRI, surgical planning, navigation, and robotic visualization delivers novel information with automated efficiency across all stages of clinical intervention.

Media Contact

Rob FrancisChief Operating OfficerReGen Scientific 416-704-3064rob@regen.care

Katrina FerroSenior Marketing Associate, Events and CommunicationsSynaptive Medical 647-243-3355katrina.ferro@synaptivemedical.com

Read more here:
ReGen Scientific First Health Institute in Canada to Introduce Evry into Proactive Brain Health Management and COVID-19 'Long-Hauler' Research and...

One of the most dramatic examples was the abrupt substitution of telemedicine for in-person visits to the doctors office. Although telemedicine technology is decades old, the pandemic demonstrated how convenient and effective it can be for many routine medical problems, Dr. Navathe said.

Feb. 10, 2021, 7:15 a.m. ET

Telemedicine is more efficient and often just as effective as an office visit. It saves time and effort for patients, especially those with limited mobility or who live in remote places. It lowers administrative costs for doctors and leaves more room in office schedules for patients whose care requires in-person visits.

Even more important, the pandemic could force a reckoning with the environmental and behavioral issues that result increasingly in prominent health risks in this country. We need to stop blaming genetics for every ailment and focus more on preventable causes of poor health like a bad diet and inactivity.

Consider, for example, the health status of those who have been most vulnerable to sickness and death from Covid-19. Aside from advanced age, about which we can do nothing, its been people with conditions that are often largely preventable: obesity, Type 2 diabetes, high blood pressure, coronary artery disease and smoking. Yet most physicians are unable to influence the behaviors that foster these health-robbing conditions.

Many people need help to make better choices for themselves, Dr. Navathe said. But the professionals who could be most helpful, like dietitians, physical trainers and behavioral counselors, are rarely covered by health insurance. The time is long overdue for Medicare and Medicaid, along with private insurers, to broaden their coverage, which can save both health and money in the long run.

Policy wonks should also pay more attention to widespread environmental risks to health. Too many Americans live in areas where healthful food is limited and prohibitively expensive and where the built environment offers little or no opportunity to exercise safely.

Individuals, too, have a role to play. The pandemic has fostered an opportunity for patients to take on a more active role in their care, Dr. Shrank said in an interview.

Originally posted here:
Pandemic Lessons in Improving the Medical System - The New York Times

Lucky Signs for the Ox

Lucky numbers for people born in the Year of the Ox are one andfour,and their lucky colours arewhite, green and yellow.Their lucky flowers aretulips and peach blossoms and their lucky directionsare north andsouth.

People born in the Year of the Ox are characterised as diligent andhard-working. They are honest, strong and dependable, with theirability to keep calm making them great leaders.

While Oxen are kind, they find it difficult to understand persuasion andnever look to be the centre of attention,which results intheir talent being hidden. Their hard-work and patience, however,helps them earn praise and successfully meet their goals.

Strengths:Patient, persistent and cautious

Weaknesses: Stubborn, less-talkative and obstructive

Oxen arevalued animals in Chinese culturebecause of their roles in agriculture and positive characteristics, such as being honest and reliable.In terms of the Yin and Yang theory, they are the yang and also representthe hours one to three in the morning and the Earthly Branch Chou.

A person born in the Year of the Rat is thought to be trustworthy, kind and gentle. In particular, men born in this year are mature, logical and put their heart into everything they do, while women are calm, loyal and never surrender to fate.

With 2021 being the Year of the Metal Ox,Chinese astrology specialists sayit is a good year for giving birth as metal symbolisesstability and longevity. Those born in the Year of the Metal Ox shall have plenty of great things in their lives.

In Chinese astrology, the 12 animal zodiac signs each have unique characteristics.

If you want to get into the swing of the festivities but dont have the foggiest how to decipher Mandarin characters, here is our handy guide to the most essential phrases.

1. / (xn nin kui l) Happy New Year!

In Mandarin:/sshin-nyen kweye-luh/

In Cantonese: /san nin fai lok/

2. / (Xn nin ho) New Year goodness!

In Mandarin: /sshin-nyen haoww/

In Cantonese: /sen-nin haow/

3. / (Gngx fci) Happiness and prosperity!

In Mandarin: /gong-sshee faa-tseye/

In Cantonese: Kunghei fatchoy /gong-hey faa-chwhy/

4. / (Bb goshng) A steady rise to high places! /on the up and up

In Mandarin: /boo-boo gaoww-shnng /

In Cantonese: /boh-boh goh-sshin /

Excerpt from:
Chinese New Year 2021: Oxen, luck and why you should avoid medicine, laundry and crying children - The Telegraph

Thanos Tzempelikos, professor in the Lyles School of Civil Engineering, has received the prestigious Leon Gaster Award from the Society of Light and Lighting as a co-author of the paper "Cross-validation and Robustness of Daylight Glare Metrics." This award is presented annually, naming the best paper of the year concerned with lighting applications. The award was presented at the societys Annual Awards evening in December in London.

Dr. David Waters is the recipient of the Center on Aging and the Life Course's (CALC) Outstanding Professor Award.Waters is professor emeritus in the College of Veterinary Medicine and a CALC faculty associate. Waters teaches biology of aging and received numerous student nominations for the award, which recognizesexceptional teaching and mentoring of emerging scholars in aging. He is director of the Center for Exceptional Longevity Studies at the Gerald P. Murphy Cancer Foundation.

* * * * *

Orr Fellowship, a postgraduate professional development program based in Indianapolis, has recently selected four Purdue seniors as Orr fellows. The Orr Fellowship is one of Indianas most celebrated nonprofit talent programs. The students Miguel Diaz, Sean ODell, Eleanor Hamilton and Hannah Vanderbosch were chosen out of nearly 1,300 applicants and will begin at one of 46 Orr Fellowship partner companies upon graduating in May. They also will participate in Orr Fellowship programming dedicated to nurturing entrepreneurship and developing strong leadership skills.

Christine McCall, a graduate research and teaching assistant in the College of Health and Human Sciences, earned a top honor from the National Council on Family Relations for a paper. McCall won the Outstanding Student and New Professional Paper Award for her paper titled A Part of Our Family? Effects of Psychiatric Service Dogs on Quality of Life and Relationship Functioning in Military-Connected Couples.

Read the original post:
Appointments, honors and activities - Purdue News Service

For centuries many have searched for the secret to a longer life. From not smoking to reducing alcohol intake, there are many ways to help lengthen ones life. Drinking more tea is another healthy approach and in particular Rooibos tea which helps reduce cancer risk, promote healthy hearts and weight loss and boosting longevity.

Rooibos teas health benefits include supporting a healthy heart, preventing cancer, managing and preventing diabetes, supporting healthy digestion, fighting inflammation, promoting stronger bones, supporting weight loss, slowing down ageing process, treating blood pressure, supporting healthy skin, fighting dandruff and supporting kidney health.

The College of Korean medicine conducted a study and found that Rooibos tea has a positive effect on heart health as it helps keep hormone levels balanced and inhibits the release of excessive hormones from the adrenal gland.

This further helps to prevent hypertension and high blood pressure.

Rooibos tea contains nothofagin and aspalathin, which are powerful chemical compounds known to calm inflammation in the vascular system and acts as a vasodilator.

READ MORE-Apple cider vinegar cleaning hacks: 10 household uses for ACV

Rooibos is associated with health benefits due to its high levels of health-promoting antioxidants, which include aspalathin and quercetin.

Antioxidants may help protect cells from damage by free radicals.

In a study published in the US National Library of Medicine National Institutes of Health, free radicals, antioxidants and how it helps with overall health was investigated.

The study noted: When an overload of free radicals cannot gradually be destroyed, their accumulation in the body generates a phenomenon called oxidative stress.

This process plays a major part in the development of chronic and degenerative illness such as cancer, autoimmune disorders, aging, cataract, rheumatoid arthritis, cardiovascular and neurodegenerative diseases.

The human body has several mechanisms to counteract oxidative stress by producing antioxidants, which are either naturally produced in situ, or externally supplied through foods and/or supplements.

Tea chemist and scientist Dr Tim Bond said: There is also evidence to show that rooibos helps protect body cells from oxidative damage.

The explanation for these effects is that rooibos tea contains a diverse range of phenolics including two unique polyphenols, aspalathin and nothofagin, which have a particularly strong anti-oxidative activity.

Rooibos tea also contains essential bone strengthening minerals including potassium, calcium and magnesium all integral for proper bone health.

Rooibos tea could also help to reduce the likelihood of brain function decline.

Continued here:
How to live longer: Rooibos tea prevents cancer and promotes healthy hearts - Express

NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE:RENX / NASDAQ: RNLX), and manufacturing partner Bio-Techne Corporation (NASDAQ: TECH), entered into a marketing and distribution agreement with Atrys Health (BME: ATRY), a biomedical company dedicated to providing diagnostic services and medical treatments of excellence. Atrys Health will offer COVID-SeroKlir and COVID-SeroIndex, Kantaro's quantitative SARS-CoV-2 IgG antibody test kits, in select European and South American territories, including Spain, Portugal, Colombia, Brazil, Peru and Chile.

Atrys Health is a distributor for Kantaro quantitative antibody tests in select European and South American territories.

The Kantaro tests have received a CE Mark for detectingthe presence and precise level of neutralizingIgG antibodiesthat areproduced as part of the immune response to COVID-19 virus exposure. The Kantaro testsare also the first and only quantitative antibody tests that do not require proprietary equipment, meaning they can be run easily in anyapproved clinical laboratory.Quantitative testing for neutralizing antibodiescaninform healthcare decision-makingandpublic health policiesworldwide.

"Atrys Health is the latest in a growing list of high-qualitydistributionpartners. This agreement represents another critical step forward in bringing the Kantaro quantitative antibody tests to doctors, patients and researchers in regions affected by COVID-19," said Sara Barrington, Kantaro's chief commercial officer. "We believe this type of antibody testing is increasingly relevant at this point in the pandemic to provide peace of mindand answer important questions about vaccine response, longevityand immunity."

Isabel Lozano, CEOof Atrys Health, said: "Our partnership with Kantaro diversifies and widens our portfolio of diagnostics at the forefront of innovation. We humbly embrace the opportunity to make the Kantaro quantitative antibody testsavailableto our customers in Europe and South America and bepart of the globaleffort to increase testing and begin to recover from the COVID-19 pandemic."

COVID-SeroKlirand COVID-SeroIndexareenzyme-linked immunosorbent assays(ELISA)that havedemonstrated 97.8% sensitivityand 99.6% specificityfor detecting COVID-19 IgG antibodies, making them highly accurate with low potential for false results.The high precision results froma two-step process that utilizes two virus antigens: the receptor-binding domain(RBD)and the full-length spike protein.

Theunderlying technology in theKantaro quantitative antibody test is based on research performed attheIcahn School of Medicine at Mount Sinai in New York City.The Mount Sinai technologyhasalreadybeen used in a highly diverse population of over 86,000 patient samples to screen for convalescent plasma donors anddetermine past infections in the clinical assessment of potentially life-threatening complications from COVID-19, including lung, kidney and cardiovascular disease. This technology has been utilized extensivelyin peer-reviewed research published in ScienceandNature.

About Kantaro Biosciences

Kantaro Biosciences, a joint venture between the Mount Sinai Health System and RenalytixAI plc, is dedicated to ensuring that high-quality diagnostic tests for critical health challenges are accessible. The company provides rigorous, results-driven and reproducible diagnostics to advance the care and well-being of people, communities and society. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. For more information, visitwww.kantarobio.comand follow Kantaro on Twitter @kantarobio.

About Bio-Techne Corporation

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $739 million in net sales in fiscal 2020 and has over 2,300 employees worldwide. For more information on Bio-Techne and its brands, please visit http://www.bio-techne.com.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality carefrom prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians are in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.orgor find Mount Sinai on Facebook, Twitterand YouTube.

About Renalytix AI plc

RenalytixAI is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company's products are being designed to make significant improvements in kidney disease diagnosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. For more information, visit renalytixai.com.

1 Intended uses of COVID-SeroKlir may vary by country.

View original content to download multimedia:http://www.prnewswire.com/news-releases/kantaro-and-atrys-health-partnership-expand-global-footprint-of-quantitative-covid-19-antibody-tests-in-europe-and-south-america-301223660.html

SOURCE Kantaro Biosciences LLC

Read more:
Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative COVID-19 Antibody Tests in Europe and South America - BioSpace